Medicinal Cannabis Matters – Friday Roundup 2nd August.
Medicinal Cannabis Matters | Friday roundup 2nd August 2024.
Medicinal Cannabis Matters – Our weekly round-up of what has been happening in the world of medicinal cannabis this week.
This week, we explore how embracing medicinal cannabis treatment can help people return to work, the benefits of CBG in reducing stress and anxiety, and how medicinal cannabis patients in New York are showing a reduction in prescription opioid use.
Embracing Medical Cannabis Treatment will get people back to work
Earlier this week, the Work and Pensions Minister announced Labour’s strategy to reintegrate 2.8 million people into the workforce. Embracing medicinal cannabis as a recognised treatment could play a pivotal role in achieving this goal.
Cannabinoid CBG reduces anxiety and stress in first human clinical trial
A lesser-known cannabinoid, Cannabigerol (CBG), is gaining popularity for its ability to reduce anxiety without the “intoxication” typically associated with cannabis.
New York medicinal cannabis patients say they have reduced their use of prescription drugs.
More than 3 out of 4 medicinal cannabis patients in New York say that medicinal cannabis has allowed them to reduce their usage of prescription drugs.
If you want to learn more about medicinal cannabis, and how it could help you better manage your condition, fill out the simple form linked below. To become a patient at the only award-winning clinic in Jersey and Guernsey take the first step today.
Check your eligibility.
https://www.medicann.co.uk/book-consultation/eligibility
Disclaimer:
This blog post and the following featured articles are for information only and any articles on external platforms may be amended at any time. Articles that we refer to in our weekly roundup do not reflect the views of Medicann.
